Soluble epoxide hydrolase: Gene structure, expression and deletion

被引:183
|
作者
Harris, Todd R.
Hammock, Bruce D. [1 ]
机构
[1] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA
关键词
EPHX2; Epoxyeicosatrienoic acid; Lipid signaling; Inflammation; Hypertension; ARACHIDONIC-ACID METABOLISM; SPONTANEOUSLY HYPERTENSIVE-RATS; INDUCED CARDIAC-HYPERTROPHY; BLOOD-PRESSURE REGULATION; INDUCED PULMONARY-HYPERTENSION; ISCHEMIA-REPERFUSION INJURY; ENDOTHELIUM IN-VITRO; EPOXYEICOSATRIENOIC ACIDS; MOUSE-LIVER; PEROXISOME PROLIFERATOR;
D O I
10.1016/j.gene.2013.05.008
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Mammalian soluble epoxide hydrolase (sEH) converts epoxides to their corresponding diols through the addition of a water molecule. sEH readily hydrolyzes lipid signaling molecules, including the epoxyeicosatrienoic acids (EETs), epoxidized lipids produced from arachidonic acid by the action of cytochrome p450s. Through its metabolism of the EETs and other lipid mediators, sEH contributes to the regulation of vascular tone, nociception, angiogenesis and the inflammatory response. Because of its central physiological role in disease states such as cardiac hypertrophy, diabetes, hypertension, and pain sEH is being investigated as a therapeutic target. This review begins with a brief introduction to sEH protein structure and function. sEH evolution and gene structure are then discussed before human small nucleotide polymorphisms and mammalian gene expression are described in the context of several disease models. The review ends with an overview of studies that have employed the sEH knockout mouse model. (c) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:61 / 74
页数:14
相关论文
共 50 条
  • [41] Polymorphisms in human soluble epoxide hydrolase
    Przybyla-Zawislak, BD
    Srivastava, PK
    Vázquez-Matías, J
    Mohrenweiser, HW
    Maxwell, JE
    Hammock, BD
    Bradbury, JA
    Enayetallah, AE
    Zeldin, DC
    Grant, DF
    MOLECULAR PHARMACOLOGY, 2003, 64 (02) : 482 - 490
  • [42] The role of soluble epoxide hydrolase in the intestine
    Ren, Yanbei
    Wang, Ting
    Yin, Jiuheng
    CELL BIOLOGY INTERNATIONAL, 2024, 48 (11) : 1612 - 1620
  • [43] Soluble epoxide hydrolase and ischemic cardiomyopathy
    Zhao, Ting-Ting
    Wasti, Binaya
    Xu, Dan-Yan
    Shen, Li
    Du, Jian-Qing
    Zhao, Shui-Ping
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 155 (02) : 181 - 187
  • [44] Phosphatase activity of soluble epoxide hydrolase
    Kramer, Jan
    Proschak, Ewgenij
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2017, 133 : 88 - 92
  • [45] Regulation of the soluble epoxide hydrolase by peroxynitrite
    Barbosa-Sicard, Eduardo
    Froemel, Timo
    Hammock, Bruce D.
    Fleming, Ingrid
    FASEB JOURNAL, 2008, 22
  • [46] The role of soluble epoxide hydrolase in preeclampsia
    Santos, Julia M.
    Park, Jung-A.
    Joiakim, Aby
    Putt, David A.
    Taylor, Robert N.
    Kim, Hyesook
    MEDICAL HYPOTHESES, 2017, 108 : 81 - 85
  • [47] Structure-Based Optimization of Arylamides as Inhibitors of Soluble Epoxide Hydrolase
    Eldrup, Anne B.
    Soleymanzadeh, Fariba
    Taylor, Steven J.
    Muegge, Ingo
    Farrow, Neil A.
    Joseph, David
    McKellop, Keith
    Man, Chuk C.
    Kukulka, Alison
    De Lombaert, Stephane
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (19) : 5880 - 5895
  • [48] Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression
    Wanbing He
    Jieping Huang
    Yang Liu
    Changming Xie
    Kun Zhang
    Xinhong Zhu
    Jie Chen
    Hui Huang
    Cell Death & Disease, 12
  • [49] Deletion of soluble epoxide hydrolase suppressed chronic kidney disease-related vascular calcification by restoring Sirtuin 3 expression
    He, Wanbing
    Huang, Jieping
    Liu, Yang
    Xie, Changming
    Zhang, Kun
    Zhu, Xinhong
    Chen, Jie
    Huang, Hui
    CELL DEATH & DISEASE, 2021, 12 (11)
  • [50] Soluble epoxide hydrolase (SEH) inhibition and Ephx2 deletion antagonize vascular remodeling
    Simpkins, Alexis N.
    Rudic, R. D.
    Hammock, Bruce D.
    Imig, John D.
    HYPERTENSION, 2008, 52 (04) : E94 - E94